MoneyWorks4Me

Omkar Pharmachem - Quaterly Results

13 Aug 2025 Evaluate
Revenue reduced marginally to stand at Rs. 1.35 millions during the quarter ended June 2025. The figure stood at Rs. 1.35 millions during the year-ago period.The Net Profit of the company slipped to Rs. 0.27 millions from Rs. 0.49 millions, a decline of -44.90% on QoQ basis.Operating Profit reported a sharp decline to 0.37 millions from 0.50 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1.35 1.35 0.00 1.35 1.35 0.00 5.40 5.40 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -33.33
PBIDT 0.37 0.50 -26.00 0.37 0.50 -26.00 2.92 2.87 1.74
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.29 -41.38
PBDT 0.37 0.50 -26.00 0.37 0.50 -26.00 2.75 2.58 6.59
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.05 0.05 0.00
PBT 0.36 0.49 -26.53 0.36 0.49 -26.53 2.70 2.53 6.72
TAX 0.09 0.00 0.00 0.09 0.00 0.00 0.69 0.64 7.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.27 0.49 -44.90 0.27 0.49 -44.90 2.01 1.89 6.35
Equity 100.84 100.84 0.00 100.84 100.84 0.00 100.84 100.84 0.00
PBIDTM(%) 27.41 37.04 -26.00 27.41 37.04 -26.00 54.07 53.15 1.74
Peers
Company Name CMP
Sagility 43.12
Prime Focus 301.65
Knowledge RealtyTrt. 112.24
Indegene 594.00
Syngene Internatl. 360.95
View more..